首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Chemotherapy

Journal Of Chemotherapy杂志,由Maney Publishing出版,于1989年创刊,Bimonthly,出版语言English,ISSN:1120-009X,E-ISSN:1973-9478。

投稿咨询
Journal Of Chemotherapy
Journal Of Chemotherapy
Journal Of Chemotherapy
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.1
CiteScore
4.1
期刊收录
SCI、SCIE

Journal Of Chemotherapy(中文译名:《化疗杂志》),ISSN:1120-009X,EISSN:1973-9478,是Maney Publishing出版的国际性学术期刊,创刊于1989年,以Bimonthly形式稳定发行,2026年总发文量约73篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.1,2025年期刊CiteScore为4.1,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Chemotherapy长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,ItalyCHINA MAINLAND、Turkey、USA、Greece、Japan、Spain等为核心发文国家与地区;UNIVERSITY OF FLORENCEUNIVERSITY OF GENOA、UNIVERSITY OF ZAGREB、CATHOLIC UNIVERSITY OF THE SACRED HEART、ISTANBUL UNIVERSITY、UNIVERSITA DELLA CAMPANIA VANVITELLI、UNIVERSITY HOSPITAL OF HERAKLION等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学 INFECTIOUS DISEASES 传染病学 PHARMACOLOGY & PHARMACY 药学
4区 4区 4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
INFECTIOUS DISEASES 传染病学 ONCOLOGY 肿瘤学 PHARMACOLOGY & PHARMACY 药学
4区 4区 4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
INFECTIOUS DISEASES 传染病学 ONCOLOGY 肿瘤学 PHARMACOLOGY & PHARMACY 药学
4区 4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q3 95 / 141

33

学科:ONCOLOGY SCIE Q3 236 / 333

29.3

学科:PHARMACOLOGY & PHARMACY SCIE Q3 240 / 356

32.7

学科:INFECTIOUS DISEASES SCIE Q3 92 / 141

35.11

学科:ONCOLOGY SCIE Q3 210 / 333

37.09

学科:PHARMACOLOGY & PHARMACY SCIE Q3 218 / 356

38.9

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q3 95 / 137

31

学科:ONCOLOGY SCIE Q4 253 / 328

23

学科:PHARMACOLOGY & PHARMACY SCIE Q3 244 / 352

30.8

学科:INFECTIOUS DISEASES SCIE Q3 95 / 137

31.02

学科:ONCOLOGY SCIE Q3 218 / 328

33.69

学科:PHARMACOLOGY & PHARMACY SCIE Q3 236 / 353

33.29


中国学者近期发文

1
Disseminated intravascular coagulation (DIC) associated with immune checkpoint inhibitor therapy: a real-world study of the FDA adverse event reporting syste

Author:Yang, Xia; Hu, Ming; Feng, Quanyao; Mo, Diwei; Feng, Fuzhen; Lei, Luwen; Pan, Xingxi

Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2026.2646812

2
Analysis of risk factors for infusion-related reactions in patients with B-cell lymphoma during obinutuzumab treatmen

Author:Wang, Zi; Zhang, Yan; Zhao, Danqing; Wei, Chong; Wang, Wei; Zhou, Daobin; Zhang, Wei

Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2026.2640329

3
Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) databas

Author:Wei, Shiju; Zhang, Zhenyu; Song, Xuhua; Chen, Rui; Chen, Siyu; Lu, Baoping

Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2612386

4
Safety analysis of vinorelbine in the real world: a pharmacovigilance study based on the FAERS databas

Author:Li, Yuhui; Shi, Zheng; Fu, Xiaoshuang; Si, Han; Song, Haolin; Fei, Yuchen; Wang, Ziqi; Wu, Qin; Song, Zhengbo

Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2612385

5
Cinobufagin regulates the microRNA-149-3p/AFF4 axis to affect the proliferation and apoptosis of cisplatin-resistant ovarian cancer cell

Author:Liu, Yunfei; Chen, Taoli; Wang, Yanpeng; Gao, Yuanyuan; Xie, Ning; Xia, Wanping; Wang, Qichuan

Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2508614

6
Identification of synthetic lethality-associated subtypes and construction of risk model to predict breast cancer prognosis and immune characteristic

Author:Tang, Jianhong; Chen, Weihong; Zou, Weibao; Cao, Shujuan

Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2512263

7
NCAPG2 promotes the proliferation, metastasis and resistance to nab-paclitaxel in gastric adenocarcinoma cell

Author:Xu, Jia; Liu, Xiaoyuan; Huang, Zebo; Zhang, Ying; Li, Xia; Cai, Dongyan

Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2498230

8
Real-world effectiveness and safety of meropenem-vaborbactam in the treatment of carbapenem-resistant enterobacterales (CRE) infections: a systematic review and meta-analysi

Author:Jin, Dongcai; Hu, Danyang; Jin, Yuhong

Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2465129

9
Impact of SARS-CoV-2 infection on clinical characteristics, antibody levels, and immune responses in patients with malignant hematological tumor

Author:Li, Yan; Zhang, Jing; Wang, Xiang; Wang, Yan; Wang, Ruili; Chen, Yongzhen; Chen, Changkai; Tian, Yuyang

Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2458377

10
The gene-panel obtained by anti-PD-1 monotherapy for melanoma reveals prognostic markers and therapeutic target

Author:Wang, Miaomiao; Zhou, Zhike; Wang, Yingying; Wang, Lixin

Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2465013


在线咨询

Journal Of Chemotherapy

国际简称:J CHEMOTHERAPY参考译名:化疗杂志

年发文量:73 CiteScore:4.1 是否预警:否 Gold OA文章占比:4.68% 研究类文章占比:84.93%

杂志社联系方式:ESIFT SRL, VIA CARLO DEL GRECO 36,, FLORENCE, ITALY, 50141

Journal Of Chemotherapy